Acceptability and effect on public and cost-effectiveness impactFriday, August 9, 2024Acceptability and demand, Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
TB vaccine market analysisFriday, August 9, 2024Accessibility, Availability, Economic impact/cost-effectivenss, Economic impact/cost-effectivenss, FInancing strategies, FInancing strategiesRead More
Impact TB vaccination for PLHIVFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Modelling the health and economic impacts of M72/AS01E vaccination and BCG-revaccination: estimates for South AfricaFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccinationFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
An investment case for new tuberculosis vaccinesFriday, August 9, 2024Availability, Policy and frameworksRead More
WHO evidence considerations for vaccine policy development for tuberculosis vaccines intended for adults and adolescentsFriday, August 9, 2024Availability, Policy and frameworksRead More
A global framework to prepare for country introduction of new TB vaccines for adults and adolescentsFriday, August 9, 2024Availability, Policy and frameworksRead More
WHO preferred product characteristics for new tuberculosis vaccineFriday, August 9, 2024Availability, Policy and frameworksRead More
